• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    183.24 Down 4.81(2.56%) Jan 30, 4:00PM EST
    |After Hours : 183.24 0.00 (0.00%) Jan 30, 5:47PM EST
    Add to Portfolio
    Prev Close:188.05
    Open:186.81
    Bid:N/A
    Ask:194.11 x 100
    1y Target Est:213.64
    Beta:1.45
    Earnings Date:Apr 22 - Apr 27 (Est.)
    Day's Range:181.67 - 189.72
    52wk Range:136.37 - 203.30
    Volume:2,144,043
    Avg Vol (3m):1,163,840
    Market Cap:36.41B
    P/E (ttm):76.22
    EPS (ttm):2.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 2.56%36.41B
    AMGNDown 2.63%115.72B
    BAXDown 1.50%38.11B

    Key Statistics

    Forward P/E (1 yr):25.17
    P/S (ttm):16.73
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :5.85
    Quarterly EPS Est (Mar-15) :1.30
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.11

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback